Trade Performance Intelligence

Score: 4/10
Trades Tracked
0/18
Profitable
N/A
Avg Change
N/A
Days Since
256 days

Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.

Stock Price at Trade vs. Today

Real market data showing how each stock moved since the congress member traded it.

Suspicious Timing Detected

5 flags
1.

Adam Smith sold $1,001 - $15,000 in $UPS on 2025-08-08 — 26 days before HR747, the "Stop Chinese Fentanyl Act of 2025," which expands sanctions on Chinese entities involved in opioid and precursor production, a potentially bearish signal for global logistics.

2.

Adam Smith sold $1,001 - $15,000 in $C on 2025-08-08 — 40 days before HR5427, the "Billionaires Income Tax Act," which proposes taxing unrealized gains annually for high-net-worth individuals, potentially impacting financial institutions.

3.

Adam Smith sold $1,001 - $15,000 in $CVS on 2025-08-08 — 41 days before HR5454, the "Medicare Advantage Prompt Pay Act," which mandates stricter payment timelines for Medicare Advantage organizations, potentially affecting healthcare providers.

4.

Adam Smith sold $1,001 - $15,000 in $CVS on 2025-08-08 — 90 days before S976, the "Insurance Fraud Accountability Act," which directly increases civil penalties for agents and brokers providing incorrect or fraudulent information, potentially impacting the insurance sector.

5.

Adam Smith sold $1,001 - $15,000 in $AAPL on 2025-08-08 — 10 days after HR4828, the "Blue Shield Privacy Act of 2025," which expands privacy protections to include biometric data, license plate numbers, workplace/school addresses, potentially impacting technology companies.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

SELL$1K-$15K
$ABBNYABB LTD SPONS ADR
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$ALKAlaska Air Group, Inc. Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$GOOGAlphabet Inc. - Class C Capital Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$AAPLApple Inc. - Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$BRK.BBerkshire Hathaway Inc. New Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$CCitigroup, Inc. Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$CVSCVS Health Corporation Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$DEDeere & Company Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$MSFTMicrosoft Corporation - Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$NEMNewmont Corporation
Aug 8, 2025 \u2022 spouse

Connected Legislative Activity

10 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillHR5111neutral

CRP Improvement and Flexibility Act of 2025

The CRP Improvement and Flexibility Act of 2025, currently in the early stages of the legislative process, aims to stabilize farm income and land use through adjustments to the Conservation Reserve Program. This bill is designed to prevent potential downturns in the agricultural sector rather than creating new growth, maintaining demand for agricultural inputs and equipment. The market impact is moderate, with agricultural equipment and commodity trading companies showing mixed recent performance.

4/10
Sep 3, 2025
$DE$AGCO$ADM$BG
BillHR5427bearish

Billionaires Income Tax Act

The Billionaires Income Tax Act (HR5427) proposes taxing unrealized gains annually for high-net-worth individuals, which would directly reduce disposable wealth for this demographic. This bill, currently in early stages and referred to the House Committee on Ways and Means, poses a structural headwind for companies reliant on luxury goods and financial services catering to these individuals. Financial firms like Citigroup, Goldman Sachs, Morgan Stanley, BlackRock, Blackstone, and The Carlyle Group could face reduced asset under management growth and decreased demand for their services if such a tax were enacted.

4/10
Sep 17, 2025
$C$GS$MS$BLK$BX$CG
BillHR4553bullish

Energy and Water Development and Related Agencies Appropriations Act, 2026

The Energy and Water Development and Related Agencies Appropriations Act, 2026 (HR4553) directly appropriates $2.755 billion for U.S. Army Corps of Engineers civil works projects, creating immediate demand for engineering, construction, and materials companies. The bill's advanced legislative stage, having been placed on the Senate Legislative Calendar, indicates a high probability of passage. Caterpillar Inc. ($CAT) has seen a 7-day change of +8.06%, Vulcan Materials Company ($VMC) +5.5%, and Martin Marietta Materials, Inc. ($MLM) +4.34%, reflecting positive market sentiment in related sectors.

7/10
Sep 10, 2025
$CAT$DE$VMC$MLM
BillHR5610neutral

Improving Drought Monitoring Act

The 'Improving Drought Monitoring Act' (HR5610) reauthorizes the U.S. Drought Monitor program through 2030 and establishes an interagency working group to integrate more in-situ data. This bill is in the early stages, having been referred to the House Committee on Agriculture, and could create new demand for advanced agricultural monitoring technologies and data analytics.

4/10
Sep 26, 2025
$AGCO$TRMB$MSFT$GOOGL
BillS2857neutral

Protecting Free Vaccines Act of 2025

The 'Protecting Free Vaccines Act of 2025' (S.2857) is in the early stages, having been referred to committee. This bill aims to codify existing mandates for ACIP-recommended immunization coverage, ensuring stable revenue for vaccine manufacturers and health insurers by preventing future disruptions to current vaccine coverage. It does not introduce new market drivers or significant changes to demand.

4/10
Sep 18, 2025
$PFE$MRNA$JNJ$UNH$ELV$CVS
BillHR5448bullish

Protecting Free Vaccines Act

The 'Protecting Free Vaccines Act' (HR5448) is an early-stage bill that, if enacted, would mandate no-cost coverage for ACIP-recommended vaccines by Medicare, Medicaid, CHIP, and private insurers until January 1, 2030. This would directly increase demand for vaccine manufacturers and shift cost burdens to health insurers and government programs. Vaccine manufacturers are positioned for sustained revenue growth, while health insurers face increased costs.

5/10
Sep 18, 2025
$PFE$MRNA$GSK$NVS$JNJ$UNH
Billneutral

CITIBANK, NATIONAL ASSOCIATION: $184M Department of State Contract

Citibank, National Association, a subsidiary of Citigroup ($C), secured a $184 million contract from the Department of State for an Application Processing Solution. While significant, this contract represents a minor portion of Citigroup's vast annual revenue, indicating a neutral but steady revenue stream.

5/10
Sep 30, 2025
$C
BillHR5605neutral

Medical Device Nonvisual Accessibility Act of 2025

The Medical Device Nonvisual Accessibility Act of 2025 (HR5605) has been introduced in the House and referred to the Committee on Energy and Commerce. This bill mandates nonvisual accessibility standards for medical devices with digital interfaces, creating new compliance requirements for manufacturers while expanding market access to blind and low-vision consumers. There is no explicit funding amount specified in the bill.

4/10
Sep 26, 2025
$MDT$ISRG$ABT$TNDM$DXCM$MSFT
BillHR747bearish

Stop Chinese Fentanyl Act of 2025

The 'Stop Chinese Fentanyl Act of 2025' (HR747) is an early-stage bill that expands sanctions on Chinese entities involved in opioid and precursor production. This legislation directly impacts U.S. companies with chemical supply chain ties to China, increasing operational costs and creating potential supply chain disruptions for chemical manufacturers and logistics firms. The bill has seen recent committee activity, indicating some legislative momentum.

4/10
Sep 3, 2025
$DD$ECL$APD$SHW$PPG$UPS
BillHR5454bearish

Medicare Advantage Prompt Pay Act

The Medicare Advantage Prompt Pay Act (HR5454) is in early legislative stages, mandating stricter payment timelines for Medicare Advantage organizations. This bill is expected to increase administrative costs and reduce cash flow flexibility for these plans, while benefiting healthcare providers through faster payments. Despite this, major Medicare Advantage providers have seen recent stock price increases, with $UNH up 12.38% in 7 days and $HUM up 10.8% in 7 days.

4/10
Sep 18, 2025
$UNH$CVS$HUM$ELV$MOH

Live Charts

$ABBNY● Sold
$ALK● Sold
$GOOG● Sold
$AAPL● Sold
$BRK.B● Sold
$C● Sold

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.